LOXL2 is a prognosis biomarker and a potential therapeutic target in intrahepatic cholangiocarcinoma
D. Bergeat
(1)
,
A. Fautrel
(2)
,
Bruno Turlin
(2, 1)
,
A. Merdrignac
(1)
,
M. Rayar
(3, 4)
,
B. Meunier
(3)
,
B. Clement
(2)
,
K. Boudjema
(2, 3)
,
C. Coulouarn
(2)
,
L Sulpice
(2)
Abstract
no abstract